Quarterly report pursuant to Section 13 or 15(d)

STOCK HOLDERS EQUITY (Tables)

v2.4.0.8
STOCK HOLDERS EQUITY (Tables)
9 Months Ended
Sep. 30, 2014
Stockholders Equity Note [Abstract]  
Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block]
A summary of equity warrants outstanding as of September 30, 2014 is presented below, all of which are fully vested.
 
 
 
 
Shares
 
July 11, 2013 formation of Holdings, 4,000,0000 warrants issued, terms 5 years, exercisable at $ 2.00, including 250,000 warrants sold to Mr. Adam Stern
 
 
4,000,000
 
July 11, 2013 recapitalization of Matinas BioPharma Inc. 1,000,000 warrants issued, terms 5 years, exercisable at $ 2.00
 
 
1,000,000
 
July and August,2013 completion of Private Placement, 7,500,000 warrants issued, terms 5 years, exercisable at $ 2.00
 
 
7,500,000
 
July 30, 2013 Placement Agent warrants issued as part of compensation for Private Placement.  Terms 5 years, exercisable at $ 2.00
 
 
750,000
 
July 30, 2013 Placement Agent warrant issued as part of compensation for Private Placement.  Terms 5 years exercisable at $ 1.00
 
 
1,500,000
 
July 30, 2013 500,000 warrants sold to Chairman of Board Mr. Herb Conrad for $ 20,000.  Terms 5 years, exercisable at $ 2.00 per share
 
 
500,000
 
Total Warrants Outstanding at September 30, 2014
 
 
15,250,000